Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 738

1.

Gitelman's syndrome with hyperphosphatemia, effectively responding to single oral magnesium oxide administration: A case report.

Miya A, Nakamura A, Kameda H, Nozu K, Miyoshi H, Atsumi T.

Medicine (Baltimore). 2019 Jul;98(28):e16408. doi: 10.1097/MD.0000000000016408.

2.

Factors with remission of fatty liver in patients with type 2 diabetes treated with ipragliflozin.

Yamauchi Y, Nakamura A, Takahashi K, Takase T, Yamamoto C, Yokota I, Atsumi T, Miyoshi H.

Endocr J. 2019 Jul 10. doi: 10.1507/endocrj.EJ19-0136. [Epub ahead of print]

3.

Reduced diffusing capacity for carbon monoxide predicts borderline pulmonary arterial pressure in patients with systemic sclerosis.

Ninagawa K, Kato M, Nakamura H, Abe N, Kono M, Fujieda Y, Oku K, Yasuda S, Ohira H, Tsujino I, Atsumi T.

Rheumatol Int. 2019 Jul 6. doi: 10.1007/s00296-019-04370-0. [Epub ahead of print]

PMID:
31280357
4.

The Pathogenicity of BPI-ANCA in a Patient With Systemic Vasculitis.

Takeda S, Watanabe-Kusunoki K, Nakazawa D, Kusunoki Y, Nishio S, Atsumi T.

Front Immunol. 2019 Jun 12;10:1334. doi: 10.3389/fimmu.2019.01334. eCollection 2019.

5.

The Picturescue Movement: Restoring Lost Photographs Following the Great East Japan Earthquake and Tsunami.

Miyamae R, Atsumi T.

Disasters. 2019 Jun 24. doi: 10.1111/disa.12365. [Epub ahead of print]

PMID:
31231844
6.

Proinsulin is sensitive to reflect glucose intolerance.

Nakamura A, Miyoshi H, Ukawa S, Nakamura K, Nakagawa T, Terauchi Y, Tamakoshi A, Atsumi T.

J Diabetes Investig. 2019 Jun 21. doi: 10.1111/jdi.13106. [Epub ahead of print]

7.

Nivolumab-induced hypophysitis causing secondary adrenal insufficiency after transient ACTH elevation.

Sekizaki T, Kameda H, Oba C, Yong Cho K, Nakamura A, Miyoshi H, Osawa T, Shinohara N, Atsumi T.

Endocr J. 2019 Jun 19. doi: 10.1507/endocrj.EJ19-0076. [Epub ahead of print]

8.

The impact of weekly teriparatide on the bone and mineral metabolism in hemodialysis patients with relatively low serum parathyroid hormone: a pilot study.

Yamamoto J, Nakazawa D, Nishio S, Ishikawa Y, Makita M, Kusunoki Y, Nagai S, Fujieda Y, Takahata M, Yamada K, Yamamura T, Yotsukura A, Saito M, Shimazaki M, Atsumi T.

Ther Apher Dial. 2019 Jun 18. doi: 10.1111/1744-9987.12867. [Epub ahead of print]

PMID:
31210004
9.

Effects of dapagliflozin and/or insulin glargine on beta cell mass and hepatic steatosis in db/db mice.

Omori K, Nakamura A, Miyoshi H, Takahashi K, Kitao N, Nomoto H, Kameda H, Cho KY, Takagi M Ag R, Hatanaka KC, Terauchi Y, Atsumi T.

Metabolism. 2019 Jun 13. pii: S0026-0495(19)30115-5. doi: 10.1016/j.metabol.2019.06.006. [Epub ahead of print]

PMID:
31202833
10.

The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: Results from the APS ACTION cohort.

Radin M, Sciascia S, Erkan D, Pengo V, Tektonidou MG, Ugarte A, Meroni P, Ji L, Belmont HM, Cohen H, Ramires de Jesús G, Branch DW, Fortin PR, Andreoli L, Petri M, Rodriguez E, Rodriguez-Pinto I, Knight JS, Atsumi T, Willis R, Gonzalez E, Lopez-Pedrera R, Rossi Gandara AP, Borges Gualhardo Vendramini M, Banzato A, Sevim E, Barbhaiya M, Efthymiou M, Mackie I, Bertolaccini ML, Andrade D; APS ACTION.

Semin Arthritis Rheum. 2019 May 2. pii: S0049-0172(19)30090-3. doi: 10.1016/j.semarthrit.2019.04.009. [Epub ahead of print]

PMID:
31153708
11.

Tumour necrosis factor alpha blockade for non-inflammatory pain: beyond inflammation?

Abe N, Kato M, Fujieda Y, Narita H, Tha KK, Atsumi T.

Scand J Rheumatol. 2019 May 28:1-3. doi: 10.1080/03009742.2019.1597383. [Epub ahead of print] No abstract available.

PMID:
31135248
12.

The development of quality indicators for systemic lupus erythematosus using electronic health data: A modified RAND appropriateness method.

Yajima N, Tsujimoto Y, Fukuma S, Sada KE, Shimizu S, Niihata K, Takahashi R, Asano Y, Azuma T, Kameda H, Kuwana M, Kohsaka H, Sugiura-Ogasawara M, Suzuki K, Takeuchi T, Tanaka Y, Tamura N, Matsui T, Mimori T, Fukuhara S, Atsumi T.

Mod Rheumatol. 2019 Jun 26:1-7. doi: 10.1080/14397595.2019.1621419. [Epub ahead of print]

PMID:
31111758
13.

Predictive value of serum amyloid a levels for requirement of concomitant methotrexate in tocilizumab initiation: A post hoc analysis of the SURPRISE study.

Kato M, Kaneko Y, Tanaka Y, Inoo M, Kobayashi-Haraoka H, Amano K, Miyata M, Murakawa Y, Yasuoka H, Hirata S, Nagasawa H, Tanaka E, Miyasaka N, Yamanaka H, Yamamoto K, Yokota I, Atsumi T, Takeuchi T.

Mod Rheumatol. 2019 Jun 7:1-8. doi: 10.1080/14397595.2019.1621026. [Epub ahead of print]

PMID:
31106666
14.

Rubber tail illusion is weakened in Ca2+-dependent activator protein for secretion 2 (Caps2)-knockout mice.

Wada M, Ide M, Atsumi T, Sano Y, Shinoda Y, Furuichi T, Kansaku K.

Sci Rep. 2019 May 17;9(1):7552. doi: 10.1038/s41598-019-43996-9.

15.

Quantitative power Doppler signal assessment in the subchondral bone region of the metacarpophalangeal joint is an effective predictor of radiographic progression in the hand of rheumatoid arthritis: a pilot study.

Fujimori M, Kamishima T, Narita A, Henmi M, Kato M, Sutherland K, Nishida M, Tanaka Y, Yutong L, Tanimura K, Atsumi T.

Rheumatol Int. 2019 Aug;39(8):1413-1421. doi: 10.1007/s00296-019-04320-w. Epub 2019 May 14.

PMID:
31089859
16.

Detection of Increased Vascular Signal in Arthritis-Prone Rats Without Joint Swelling Using Superb Microvascular Imaging Ultrasonography.

Horie T, Nishida M, Tanimura S, Kamishima T, Tamai E, Morimura Y, Nishibata Y, Masuda S, Nakazawa D, Tomaru U, Atsumi T, Ishizu A.

Ultrasound Med Biol. 2019 Aug;45(8):2086-2093. doi: 10.1016/j.ultrasmedbio.2019.04.002. Epub 2019 May 11.

PMID:
31085028
17.

A case report dysregulated neutrophil extracellular traps in a patient with propylthiouracil-induced anti-neutrophil cytoplasmic antibody-associated vasculitis.

Watanabe-Kusunoki K, Abe N, Nakazawa D, Karino K, Hattanda F, Fujieda Y, Nishio S, Yasuda S, Ishizu A, Atsumi T.

Medicine (Baltimore). 2019 Apr;98(17):e15328. doi: 10.1097/MD.0000000000015328.

18.

Has lupus anticoagulant testing had its day?

Fujieda Y, Atsumi T.

Nat Rev Rheumatol. 2019 Jun;15(6):324-325. doi: 10.1038/s41584-019-0218-6. No abstract available.

PMID:
31000789
19.

Disseminated subcutaneous nodules and destructive polyarthritis.

Abe N, Fujieda Y, Amengual O, Atsumi T.

BMJ. 2019 Apr 17;365:l1344. doi: 10.1136/bmj.l1344. No abstract available.

PMID:
30996027
20.

Pathogenic roles of anti-C1q antibodies in recurrent pregnancy loss.

Ohmura K, Oku K, Kitaori T, Amengual O, Hisada R, Kanda M, Shimizu Y, Fujieda Y, Kato M, Bohgaki T, Horita T, Yasuda S, Sugiura-Ogasawara M, Atsumi T.

Clin Immunol. 2019 Jun;203:37-44. doi: 10.1016/j.clim.2019.04.005. Epub 2019 Apr 8.

PMID:
30974291
21.

Successful treatment of tocilizumab-resistant large vessel pulmonary arteritis with infliximab.

Tanimura S, Kato M, Abe N, Ohira H, Tsujino I, Atsumi T.

Immunol Med. 2018 Mar;41(1):39-42. doi: 10.1080/09114300.2018.1451616. Epub 2018 Apr 3.

PMID:
30938259
22.

The presence of anti-neutrophil extracellular trap antibody in patients with microscopic polyangiitis.

Hattanda F, Nakazawa D, Watanabe-Kusunoki K, Kusunoki Y, Shida H, Masuda S, Nishio S, Tomaru U, Atsumi T, Ishizu A.

Rheumatology (Oxford). 2019 Jul 1;58(7):1293-1298. doi: 10.1093/rheumatology/kez089.

PMID:
30897615
23.

Patients With Refractory Out-of-Cardiac Arrest and Sustained Ventricular Fibrillation as Candidates for Extracorporeal Cardiopulmonary Resuscitation - Prospective Multi-Center Observational Study.

Nakashima T, Noguchi T, Tahara Y, Nishimura K, Ogata S, Yasuda S, Onozuka D, Morimura N, Nagao K, Gaieski DF, Asai Y, Yokota H, Nara S, Hase M, Atsumi T, Sakamoto T; SAVE-J Group.

Circ J. 2019 Apr 25;83(5):1011-1018. doi: 10.1253/circj.CJ-18-1257. Epub 2019 Mar 20.

24.

Rheumatology practice in Japan: challenges and opportunities.

Oku K, Atsumi T.

Rheumatol Int. 2019 Mar 19. doi: 10.1007/s00296-019-04281-0. [Epub ahead of print] Review.

PMID:
30888472
25.

Breakdown of Autonomously Functioning Thyroid Nodule Accompanied by Acromegaly After Octreotide Treatment.

Nomoto H, Kameda H, Nakamura A, Tsuchida K, Nagai S, Atsumi T, Miyoshi H.

Front Endocrinol (Lausanne). 2019 Mar 1;10:131. doi: 10.3389/fendo.2019.00131. eCollection 2019.

26.

Circulating plasmablasts contribute to antiphospholipid antibody production, associated with type I interferon upregulation.

Hisada R, Kato M, Sugawara E, Kanda M, Fujieda Y, Oku K, Bohgaki T, Amengual O, Horita T, Yasuda S, Atsumi T.

J Thromb Haemost. 2019 Jul;17(7):1134-1143. doi: 10.1111/jth.14427. Epub 2019 Mar 30.

PMID:
30864219
27.

Ecological, phylogenetical, and pharmacognostical characteristics of Aconitum kiyomiense endemic to Hida highlands, Takayama city, Gifu Prefecture, Japan.

Minami M, Yasueda M, Shirako T, Murakami T, Mori T, Fujii T, Atsumi T, Shibata T, Kadota Y.

J Nat Med. 2019 Jun;73(3):523-532. doi: 10.1007/s11418-019-01296-6. Epub 2019 Mar 12.

PMID:
30863932
28.

Safety and tolerability of sifalimumab, an anti-interferon-α monoclonal antibody, in Japanese patients with systemic lupus erythematosus: A multicenter, phase 2, open-label study.

Takeuchi T, Tanaka Y, Matsumura R, Saito K, Yoshimura M, Amano K, Atsumi T, Suematsu E, Hayashi N, Wang L, Tummala R.

Mod Rheumatol. 2019 Feb 21:1-8. doi: 10.1080/14397595.2019.1583832. [Epub ahead of print]

PMID:
30791804
29.

Anti-cyclic citrullinated peptide antibody titers decrease in rheumatoid arthritis patients treated with tocilizumab: A pilot study.

Noguchi A, Yasuda S, Hisada R, Kato M, Oku K, Bohgaki T, Suzuki M, Matsumoto Y, Atsumi T.

Mod Rheumatol. 2019 Feb 21:1-6. doi: 10.1080/14397595.2019.1583784. [Epub ahead of print]

PMID:
30789096
30.

Case of fulminant type 1 diabetes induced by the anti-programmed death-ligand 1 antibody, avelumab.

Shibayama Y, Kameda H, Ota S, Tsuchida K, Cho KY, Nakamura A, Miyoshi H, Atsumi T.

J Diabetes Investig. 2019 Feb 9. doi: 10.1111/jdi.13022. [Epub ahead of print]

31.

The comparison of real world and core laboratory antiphospholipid antibody ELISA results from antiphospholipid syndrome alliance for clinical trials & international networking (APS ACTION) clinical database and repository analysis.

Sciascia S, Willis R, Pengo V, Krilis S, Andrade D, Tektonidou MG, Ugarte A, Chighizola C, Branch DW, Levy RA, Nalli C, Fortin PR, Petri M, Rodriguez E, Rodriguez-Pinto I, Atsumi T, Nascimento I, Rosa R, Banzato A, Erkan D, Cohen H, Efthymiou M, Mackie I, Bertolaccini ML; APS ACTION.

Thromb Res. 2019 Mar;175:32-36. doi: 10.1016/j.thromres.2019.01.010. Epub 2019 Jan 18.

PMID:
30685523
32.

Formation and Disordered Degradation of Neutrophil Extracellular Traps in Necrotizing Lesions of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis.

Masuda S, Nonokawa M, Futamata E, Nishibata Y, Iwasaki S, Tsuji T, Hatanaka Y, Nakazawa D, Tanaka S, Tomaru U, Kawakami T, Atsumi T, Ishizu A.

Am J Pathol. 2019 Apr;189(4):839-846. doi: 10.1016/j.ajpath.2019.01.007. Epub 2019 Jan 21.

PMID:
30677396
33.

Potential therapeutics for antiphospholipid antibody associated thrombocytopenia: a systematic review and meta-analysis.

Abe N, Oku K, Amengual O, Fujieda Y, Kato M, Bohgaki T, Yasuda S, Mori R, Morishita E, Suzuki-Inoue K, Atsumi T.

Mod Rheumatol. 2018 Dec 17:1-21. doi: 10.1080/14397595.2018.1558934. [Epub ahead of print]

PMID:
30557100
34.

Anti-TIF1γ antibody predicted malignancy of thymic tumor with dermatomyositis as an "autoimmune tumor marker": A case report.

Karino K, Fujieda Y, Kawamura T, Abe N, Shimoyama S, Kono M, Kato M, Yasuda S, Atsumi T.

Medicine (Baltimore). 2018 Dec;97(49):e13563. doi: 10.1097/MD.0000000000013563.

35.

Preferential attentional engagement drives attentional bias to snakes in Japanese macaques (Macaca fuscata) and humans (Homo sapiens).

Masataka N, Koda H, Atsumi T, Satoh M, Lipp OV.

Sci Rep. 2018 Dec 11;8(1):17773. doi: 10.1038/s41598-018-36108-6.

36.

Effects of crushed Schisandra Fruit on the content of lignans in Kampo decoction.

Atsumi T, Yokoyama Y, Yokogawa T, Makino T, Ohtsuka I.

J Nat Med. 2019 Mar;73(2):381-387. doi: 10.1007/s11418-018-1271-1. Epub 2018 Dec 10.

PMID:
30535786
37.

Antiphospholipid score is a novel risk factor for idiopathic osteonecrosis of the femoral head in patients with systemic lupus erythematosus.

Hisada R, Kato M, Ohnishi N, Sugawara E, Fujieda Y, Oku K, Bohgaki T, Amengual O, Yasuda S, Atsumi T.

Rheumatology (Oxford). 2019 Apr 1;58(4):645-649. doi: 10.1093/rheumatology/key365.

PMID:
30521019
38.

Efficacy of dual antiplatelet therapy for preventing recurrence of arterial thrombosis in patients with antiphospholipid syndrome.

Ohnishi N, Fujieda Y, Hisada R, Nakamura H, Kato M, Oku K, Bohgaki T, Amengual O, Yasuda S, Atsumi T.

Rheumatology (Oxford). 2019 Jun 1;58(6):969-974. doi: 10.1093/rheumatology/key340.

PMID:
30508199
39.

Genetic determinants and an epistasis of LILRA3 and HLA-B*52 in Takayasu arteritis.

Terao C, Yoshifuji H, Matsumura T, Naruse TK, Ishii T, Nakaoka Y, Kirino Y, Matsuo K, Origuchi T, Shimizu M, Maejima Y, Amiya E, Tamura N, Kawaguchi T, Takahashi M, Setoh K, Ohmura K, Watanabe R, Horita T, Atsumi T, Matsukura M, Miyata T, Kochi Y, Suda T, Tanemoto K, Meguro A, Okada Y, Ogimoto A, Yamamoto M, Takahashi H, Nakayamada S, Saito K, Kuwana M, Mizuki N, Tabara Y, Ueda A, Komuro I, Kimura A, Isobe M, Mimori T, Matsuda F.

Proc Natl Acad Sci U S A. 2018 Dec 18;115(51):13045-13050. doi: 10.1073/pnas.1808850115. Epub 2018 Nov 29.

40.

Spontaneous Discriminative Response to the Biological Motion Displays Involving a Walking Conspecific in Mice.

Atsumi T, Ide M, Wada M.

Front Behav Neurosci. 2018 Nov 6;12:263. doi: 10.3389/fnbeh.2018.00263. eCollection 2018.

41.

The generative power of metaphor: long-term action research on disaster recovery in a small Japanese village.

Atsumi T, Seki Y, Yamaguchi H.

Disasters. 2019 Apr;43(2):355-371. doi: 10.1111/disa.12314. Epub 2018 Nov 15.

PMID:
30431187
42.

Clinical profiles and risk assessment in patients with antiphospholipid antibodies.

Kato M, Hisada R, Atsumi T.

Expert Rev Clin Immunol. 2019 Jan;15(1):73-81. doi: 10.1080/1744666X.2019.1543025. Epub 2018 Nov 13.

PMID:
30381978
43.

Relationship Between Visceral Fat and Plasma Aldosterone Concentration in Patients With Primary Aldosteronism.

Shibayama Y, Wada N, Baba S, Miyano Y, Obara S, Iwasaki R, Nakajima H, Sakai H, Usubuchi H, Terae S, Nakamura A, Atsumi T.

J Endocr Soc. 2018 Sep 17;2(11):1236-1245. doi: 10.1210/js.2018-00187. eCollection 2018 Nov 1.

44.

Clinical significance of anti-DNA/N-methyl-D-aspartate receptor 2 antibodies in de novo and post-steroid cases with neuropsychiatric systemic lupus erythematosus.

Fujieda Y, Mader S, Jeganathan V, Arinuma Y, Shimizu Y, Kato M, Oku K, Minami A, Shimizu C, Yasuda S, Atsumi T.

Int J Rheum Dis. 2019 Mar;22(3):443-448. doi: 10.1111/1756-185X.13392. Epub 2018 Oct 24.

PMID:
30358102
45.

Incidence and risk factors for reactivation from resolved hepatitis B virus in rheumatoid arthritis patients treated with biological disease-modifying antirheumatic drugs.

Watanabe T, Fukae J, Fukaya S, Sawamukai N, Isobe M, Matsuhashi M, Shimizu M, Akikawa K, Tanimura K, Atsumi T, Koike T.

Int J Rheum Dis. 2019 Apr;22(4):574-582. doi: 10.1111/1756-185X.13401. Epub 2018 Oct 18.

PMID:
30338649
46.

Effect of switching from pioglitazone to the sodium glucose co-transporter-2 inhibitor dapagliflozin on body weight and metabolism-related factors in patients with type 2 diabetes mellitus: An open-label, prospective, randomized, parallel-group comparison trial.

Cho KY, Nakamura A, Omori K, Takase T, Miya A, Manda N, Kurihara Y, Aoki S, Atsumi T, Miyoshi H.

Diabetes Obes Metab. 2019 Mar;21(3):710-714. doi: 10.1111/dom.13557. Epub 2018 Nov 8.

47.

Histopathological classification of anti-neutrophil cytoplasmic antibody-associated glomerulonephritis in a nationwide Japanese prospective 2-year follow-up cohort study.

Yamagata K, Usui J, Nagata M, Sugiyama H, Sada KE, Muso E, Harigai M, Amano K, Atsumi T, Fujimoto S, Yuzawa Y, Kobayashi M, Saito T, Ito T, Hirawa N, Homma S, Dobashi H, Tsuboi N, Ishizu A, Arimura Y, Makino H, Matsuo S; Research Committee of Intractable Renal Disease and the Research Committee of Intractable Vasculitis Syndrome of the Ministry of Health, Labour, and Welfare of Japan.

Clin Exp Nephrol. 2019 Mar;23(3):387-394. doi: 10.1007/s10157-018-1656-1. Epub 2018 Oct 10.

PMID:
30306344
48.

Pathogenic role of antiphospholipid antibodies: an update.

Fujieda Y, Amengual O, Atsumi T.

Lupus. 2018 Nov;27(13):2012-2013. doi: 10.1177/0961203318802016. Epub 2018 Oct 3. No abstract available.

PMID:
30282558
49.

NEDD4 Is Involved in Inflammation Development during Keloid Formation.

Fujita M, Yamamoto Y, Jiang JJ, Atsumi T, Tanaka Y, Ohki T, Murao N, Funayama E, Hayashi T, Osawa M, Maeda T, Kamimura D, Murakami M.

J Invest Dermatol. 2019 Feb;139(2):333-341. doi: 10.1016/j.jid.2018.07.044. Epub 2018 Sep 28.

PMID:
30273597
50.

Detection of Autoreactive Type II NKT Cells: A Pilot Study of Comparison Between Healthy Individuals and Patients with Vasculitis.

Nishioka Y, Sonoda T, Shida H, Kusunoki Y, Hattanda F, Tanimura S, Uozumi R, Yamada M, Nishibata Y, Masuda S, Nakazawa D, Tomaru U, Atsumi T, Ishizu A.

Cytometry A. 2018 Nov;93(11):1157-1164. doi: 10.1002/cyto.a.23618. Epub 2018 Sep 25.

PMID:
30253046

Supplemental Content

Loading ...
Support Center